Literature DB >> 11068051

Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs.

N Yamamoto1, T Takizawa, Y Iwanaga, N Shimizu, N Yamamoto1.   

Abstract

EBV-encoded small RNAs (EBERs) are non-polyadenylated and abundantly transcribed RNAs, whose functions have not yet been fully elucidated. Here, we report that the EBV-negative B lymphoma cell line, BJAB, was rendered more malignant and resistant to apoptosis by EBERs. EBER-transfected cells exhibited enhanced growth potential in SCID mice as well as in soft agar, and showed resistance to apoptotic stimuli in comparison with the vector control. EBERs inhibited the activity of the double-stranded RNA-dependent protein kinase, PKR, which is reputed to act as a tumor-suppressor. These results suggest that EBERs play an important role in the pathogenesis of EBV-associated malignancies through the inhibition of PKR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068051     DOI: 10.1016/s0014-5793(00)02145-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus.

Authors:  Momchilo Vuyisich; Richard J Spanggord; Peter A Beal
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

2.  EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN.

Authors:  Mrinal Samanta; Dai Iwakiri; Teru Kanda; Tadaatsu Imaizumi; Kenzo Takada
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

3.  Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.

Authors:  Misako Yajima; Teru Kanda; Kenzo Takada
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.

Authors:  Pankaj Kumar; Masanao Murakami; Rajeev Kaul; Abhik Saha; Qiliang Cai; Erle S Robertson
Journal:  Future Virol       Date:  2009-01       Impact factor: 1.831

Review 5.  RNA families in Epstein-Barr virus.

Authors:  Walter N Moss; Nara Lee; Genaro Pimienta; Joan A Steitz
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

Review 6.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

Review 7.  Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis.

Authors:  Whitney L Bullard; Erik K Flemington; Rolf Renne; Scott A Tibbetts
Journal:  Trends Cancer       Date:  2018-10-10

8.  Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-03-20       Impact factor: 7.012

9.  Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.

Authors:  M Chin; M Herscovitch; N Zhang; D J Waxman; T D Gilmore
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

10.  Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus.

Authors:  Claire E Repellin; Penelope M Tsimbouri; Adrian W Philbey; Joanna B Wilson
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.